Tian Ruixiang Holdings Ltd. is moving forward with plans to acquire Singapore’s top three medical technology leaders as part of a strategic initiative to expand its AI-driven healthcare ecosystem across Southeast Asia and the Asia-Pacific. The integration of these medical tech companies is expected to bring proprietary AI diagnostic platforms to TIRX’s insurance clinic networks, enhancing early disease detection and personalized treatment. The transactions, subject to customary closing conditions, are anticipated to be completed within the next 12 months, positioning the company as a leading force in AI-powered healthcare in the region.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tian Ruixiang Holdings Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9653753-en) on February 12, 2026, and is solely responsible for the information contained therein.